Your browser doesn't support javascript.
loading
Daratumumab in Pediatric Relapsed/Refractory Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma: DELPHINUS Study.
Bhatla, Teena; Hogan, Laura; Teachey, David Trent; Bautista, Franciso; Moppett, John P; Velasco, Pablo; Micalizzi, Concetta; Rossig, Claudia; Shukla, Neerav Narendra; Gilad, Gil; Locatelli, Franco; Baruchel, André; Zwaan, Michel; Bezler, Natalie S; Rubio-San-Simón, Alba; Taussig, David; Raetz, Elizabeth A; Mao, Zhengwei J; Wood, Brent; Alvarez Arias, Diana; Krevvata, Maria; Nnane, Ivo; Bandyopadhyay, Nibedita; Lopez Solano, Lorena; Dennis, Robyn M; Carson, Robin; Vora, Ajay.
Affiliation
  • Bhatla T; Department of Pediatrics, Children's Hospital of New Jersey at Newark Beth Israel Medical Center, Newark, New Jersey, United States.
  • Hogan L; Department of Pediatrics, Stony Brook Children's, United States.
  • Teachey DT; Division of Oncology, Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, United States.
  • Bautista F; Princess Máxima Centrum, Utrecht, Netherlands.
  • Moppett JP; Paediatric Haematology, Bristol Royal Hospital for Children, United Kingdom.
  • Velasco P; University Hospital Vall d´Hebron, BARCELONA, Spain.
  • Micalizzi C; Istituto Giannina Gaslini, GENOVA, Italy.
  • Rossig C; University Children's Hospital Münster, Muenster, Germany.
  • Shukla NN; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, United States.
  • Gilad G; Department of Pediatric Hematology-Oncology, Schneider Children's Medical Center of Israel, Petach Tikva, Israel; Sackler Faculty of Medicine, Tel Aviv University, Petach Tikva, Israel.
  • Locatelli F; Pediatric Hematology and Immunology Department, Robert Debré University Hospital (APHP and Université de Paris Cité), France.
  • Baruchel A; Pediatric Hematology and Immunology Department, Robert Debré University Hospital (APHP and Université de Paris Cité), France.
  • Zwaan M; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands; Department of Pediatric Oncology, Erasmus MC-Sophia Children's Hospital, Netherlands.
  • Bezler NS; Division of Hematology and Oncology, Connecticut Children's, Hartford, Connecticut, United States.
  • Rubio-San-Simón A; Hospital Infantil Universitario Niño Jesús, Madrid, Spain.
  • Taussig D; Centre for Molecular Pathology, The Royal Marsden Hospital, Institute of Cancer Research, United Kingdom.
  • Raetz EA; New York University Langone Medical Center, United States.
  • Mao ZJ; Department of Laboratory Medicine, University of Washington, United States.
  • Wood B; Department of Laboratory Medicine, University of Washington, United States.
  • Alvarez Arias D; Janssen Research & Development, LLC, Spring House, Pennsylvania, United States.
  • Krevvata M; Janssen Research & Development, LLC, Spring House, Pennsylvania, United States.
  • Nnane I; Janssen Research & Development, LLC, Spring House, Pennsylvania, United States.
  • Bandyopadhyay N; Janssen Research & Development, LLC, Raritan, New Jersey, United States.
  • Lopez Solano L; Janssen Research & Development, LLC, Middletown, New Jersey, United States.
  • Dennis RM; Janssen Research & Development, LLC, Lanoka Harbor, New Jersey, United States.
  • Carson R; Janssen R&D, Springhouse, Pennsylvania, United States.
  • Vora A; Department of Haematology, Great Ormond Street Hospital for Children, United States.
Blood ; 2024 Aug 16.
Article de En | MEDLINE | ID: mdl-39158071

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: Blood Année: 2024 Type de document: Article Pays d'affiliation: États-Unis d'Amérique Pays de publication: États-Unis d'Amérique

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: Blood Année: 2024 Type de document: Article Pays d'affiliation: États-Unis d'Amérique Pays de publication: États-Unis d'Amérique